date,title,source
Oct-22-18,RedHill Biopharma Announces Additional Data from Positive Phase III Study of RHB-104 in Crohns Disease at United European Gastroenterology (UEG) Week 2018,GlobeNewswire
Oct-25-18,RedHill Biopharma to Present at the BIO-Europe 2018 Conference,GlobeNewswire
Nov-06-18,"RedHill Biopharma to Host Third Quarter 2018 Financial Results Conference Call on November 13, 2018",GlobeNewswire
Nov-13-18,RedHill Biopharma Reports Third Quarter 2018 Financial Results and Business Highlights,GlobeNewswire
Nov-21-18,IntelGenx's NDA Resubmission for Rizaport Gets FDA Acceptance,Zacks
Nov-29-18,RedHill Biopharma to Present at BMO 2018 Prescriptions for Success Healthcare Conference,GlobeNewswire
Dec-03-18,RedHill Biopharma's antibiotic succeeds in late-stage study,Reuters
Dec-04-18,RedHill Biopharma Announces Proposed Public Offering of its American Depositary Shares,GlobeNewswire
Dec-06-18,RedHill Biopharma Announces Pricing of $20 Million Underwritten Offering,GlobeNewswire
Dec-11-18,RedHill Biopharma Announces Closing of $20 Million Underwritten Offering,GlobeNewswire
Dec-12-18,RedHill closes $20M public offering to prep commercialization of new drug,American City Business Journals
Feb-19-19,RedHill Biopharma to Present at the 8th Annual SVB Leerink Healthcare Conference,GlobeNewswire
Feb-20-19,"RedHill Biopharma Strengthens Management Team with Appointment of Rick D. Scruggs as Chief Operating Officer, U.S. Operations",GlobeNewswire
Feb-21-19,"RedHill Biopharma to Host Full-Year 2018 Financial Results Conference Call on February 26, 2019",GlobeNewswire
